Flagship Harbor Advisors, LLC Insulet Corp Transaction History

Flagship Harbor Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$215.97 - $265.89 $124,398 - $153,152	-576 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$192.55 - $236.59 $770 - $946	-4 Reduced 0.69%	576 $136,000
Q2 2020 Jul 31, 2020	BUY	$159.17 - $224.73 $11,460 - $16,180	72 Added 14.17%	580 $112,000
Q4 2019 Feb 14, 2020	SELL	$144.81 - $186.0 $28,962 - $37,200	-200 Reduced 28.25%	508 $87,000
Q3 2019 Oct 22, 2019	SELL	$117.35 - $167.95 $101,977 - $145,948	-869 Reduced 55.1%	708 $116,000
Q2 2019 Jul 22, 2019	BUY	$82.13 - $120.73 $10,266 - $15,091	125 Added 8.61%	1,577 $188,000
Q1 2019 Apr 15, 2019	BUY	$72.44 - $101.87 $83,450 - $117,354	1,152 Added 384.0%	1,452 $138,000
Q3 2018 Nov 05, 2018	BUY	$81.43 - $108.13 $24,429 - $32,439	300 New	300 $32,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.